Single drug provides first evidence of ‘nearly universal’ pharmacological chaperone for rare disease

A study published in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilize nearly all mutated versions of a human protein, regardless of where the mutation is in the sequence.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup